The new EU proposal to revamp its pharmaceutical regulations. The main aim is to give people a better and more affordable access to medicines.
From what I can see, there are mixed feelings about the proposal. On one hand, consumer groups and civil society organizations are applauding the EU’s efforts to make medicines more accessible. On the other hand, the pharmaceutical industry is a bit skeptical.
So, what’s in the proposal? Well, the EU is looking to shorten the period in which pharmaceutical companies can sell their medicines without competition from 10 years to just 8 years. They’re also working towards closing the gap in access to medicines among different EU member states.
It’s interesting to see how this will all play out. What are your thoughts on the EU Pharmaceutical Regulations Proposal?
🔍 Discover the cost-effectiveness of pharmacogenetic screening in treating Major Depressive Disorder (MDD).
This approach could save costs and improve patient outcomes in the Spanish National Health System. Read more to understand the potential benefits and future implications. 🌐💡
#SyenzaNews #Pharmacogenetics #MajorDepression #CostEffectiveness #HealthcareInnovation
🌟 Healthy Ageing Index and Assessment of Age-Related Outcomes 🌟
📊 Unlocking the Secrets of Healthy Ageing in Singapore! Discover the significance of the Healthy Ageing Index (HAI) in predicting age-related outcomes! Learn how this tool can help promote healthy ageing and improve quality of life. 👵👴
#SyenzaNews #HealthyAgeing #SingaporeHealthcare #AgeingPopulation #HealthOutcomes
Thailand’s healthcare system is a beacon of efficiency and effectiveness. Achieving Universal Health Coverage in 2002, the country has made remarkable strides in health outcomes, despite spending less compared to other upper-middle-income countries.
Learn how Thailand’s use of Health Technology Assessment (HTA) has played a crucial role in this success and the future steps to address current challenges. 🌍💉
#SyenzaNews #Healthcare #UniversalHealthCoverage #HTA #Innovation
SPEAK WITH US
CORRESPONDENCE ADDRESS
1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA
WRITE US
JOIN NEWSLETTER
